Concomitant renal cell carcinoma and chronic myelogenous leukemia: use of a targeted approach

por Pal, S.K., Gupta, R.K., Dosik, G., Figlin, R.A.
Publicado 2009

The effects of granulocyte-macrophage colony-stimulating factor on tumour-infiltrating lymphocytes from renal cell carcinoma.

por Steger, G. G., Kaboo, R., deKernion, J. B., Figlin, R., Belldegrun, A.
Publicado 1995

Q-TWiST analysis to estimate overall benefit for patients with metastatic renal cell carcinoma treated in a phase III trial of sunitinib vs interferon-α

por Patil, S, Figlin, R A, Hutson, T E, Michaelson, M D, Negrier, S, Kim, S T, Huang, X, Motzer, R J
Publicado 2012

Specific immunotherapy of MUC1-positive adenocarcinomas with a recombinant vaccinia virus expressing MUC1 and IL-2

por Bizouarne, N, Squiban, P, Acres, B, Balloul, JM, Ohresser, MA, Figlin, R, Belldegrun, A, Herrman, R, Rochlitz, C
Publicado 2001

Everolimus in metastatic renal cell carcinoma patients intolerant to previous VEGFr-TKI therapy: a RECORD-1 subgroup analysis

por Bracarda, S, Hutson, T E, Porta, C, Figlin, R A, Calvo, E, Grünwald, V, Ravaud, A, Motzer, R, Kim, D, Anak, O, Panneerselvam, A, Escudier, B
Publicado 2012

Integrating cytokines and angiogenic factors and tumour bulk with selected clinical criteria improves determination of prognosis in advanced renal cell carcinoma

por Zurita, A J, Gagnon, R C, Liu, Y, Tran, H T, Figlin, R A, Hutson, T E, D'Amelio Jr, A M, Sternberg, C N, Pandite, L N, Heymach, J V
Publicado 2017

Joint association of polymorphism of the FGFR4 gene and mutation TP53 gene with bladder cancer prognosis

por Yang, Y C, Lu, M L, Rao, J Y, Wallerand, H, Cai, L, Cao, W, Pantuck, A, Dalbagni, G, Reuter, V, Figlin, R A, Belldegrun, A, Cordon-Cardo, C, Zhang, Z F
Publicado 2006

Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma

por Hutson, T E, Bukowski, R M, Rini, B I, Gore, M E, Larkin, J M, Figlin, R A, Barrios, C H, Escudier, B, Lin, X, Fly, K, Martell, B, Matczak, E, Motzer, R J
Publicado 2014

1611P Health-related quality of life, vaccine uptake and immune response among cancer patients undergoing treatment during the COVID-19 pandemic

por Figueiredo, J.C., Merin, N., Ihenacho, U., Hamid, O., Hendifar, A.E., Vescio, R., Paquette, R., Natale, R.B., Darrah, J., Basho, R., McArthur, H., Nguyen, N., Punwani, N., Herrera, E., Cheng, S., Salvy, S-J., Datta, G., Figlin, R., Merchant, A., Reckamp, K.L.
Publicado 2021